BioSpace News Archive

Company to submit the ISO 13485 and CE Mark certified fluorecare® test kit under FDA’s EAU and 510(k) clearance for U.S. commercial use

Preclinical research from Dr. Charles Brenner and a team of leading scientists from three US universities concludes that key steps in coronavirus infection and innate immunity involve a tug-of-war with cellular NAD

Deployment expands access to PacBio’s highly accurate long reads on the African continent for a variety of applications, from ethnic-specific reference genomes to COVID-19 research

Evaluation of Fadraciclib and Seliciclib to Promote Apoptosis of Inflammatory Neutrophils in the Setting of COVID-19 Lung Injury

Ionis Pharmaceuticals, Inc. announced that its partner Roche, also known as Genentech in the United States, has completed enrollment for GENERATION HD1, a global Phase 3 study evaluating the efficacy and safety of tominersen, an investigational antisense therapy for people living with Huntington’s disease.

CONMED Corporation announced an amendment to its existing credit agreement, including adjustments to, and suspension of, certain debt covenant thresholds.

Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced the first patents awarded by the U.S. Patent and Trademark Office (USPTO) for its ground-breaking XBAR® technology designed for 5G and WiFi.

SAN CLEMENTE, Calif., April 20, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2020 earnings release and conference call. The Company will release its first quarter 2020 results on Thursday, May 7 th , 2020 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerni

Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it will host a conference call with members of Strongbridge’s management team on Wednesday, May 6 at 8:30 a.m. ET to discuss the Company’s first quarter 2020 financial results and to provide a business

NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will be conducting a virtual presentation in conjunction with the Planet MicroCap Showcase Virtual Investor Conference on Wednesday, April 22, 2020, at 12:00 p.m. ET. In addition, Dr. Lederman will participate in a MicroCap Investing Workshop panel discussion titled, “Potential Solutio